fulvestrant has been researched along with 3-nitrotyrosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ikeda, K; Xu, JW; Yamori, Y | 1 |
Agin, A; Boehm, N; Charloux, A; Geny, B; Oswald-Mammosser, M; Rashid, S; Schini-Kerth, V | 1 |
2 other study(ies) available for fulvestrant and 3-nitrotyrosine
Article | Year |
---|---|
Genistein inhibits expressions of NADPH oxidase p22phox and angiotensin II type 1 receptor in aortic endothelial cells from stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Anilides; Animals; Aorta, Thoracic; Cells, Cultured; Endothelin-1; Endothelium, Vascular; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Fulvestrant; Genistein; Hypertension; Male; Membrane Transport Proteins; NADPH Dehydrogenase; NADPH Oxidases; Phosphoproteins; PPAR gamma; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Signal Transduction; Stroke; Superoxides; Tyrosine; Vasoconstrictor Agents | 2004 |
Effect of the oestrogen receptor antagonist fulvestrant on the cirrhotic rat lung.
Topics: Animals; Cell Adhesion Molecules; Disease Models, Animal; Estradiol; Estrogen Receptor Antagonists; Fulvestrant; Heme Oxygenase (Decyclizing); Hepatopulmonary Syndrome; Liver Cirrhosis, Biliary; Lung; Macrophages; Male; Microfilament Proteins; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphoproteins; Phosphorylation; Rats, Wistar; Tyrosine; Vascular Endothelial Growth Factor A | 2015 |